Health, Safety and Environment (HSE) in Brazil
Brazilian Health Regulatory Agency (Anvisa) has enacted a ban on the sale and use of phenol-based products in both general health and aesthetic procedures. This prohibition was formalized under Resolution No. 2384, issued on June 24, 2024. The decision comes Read More …
Brazil’s National Health Surveillance Agency (ANVISA) has initiated the process of gathering contributions for new regulations governing epidemiological surveillance activities at ports and airports. This regulatory update aims to bolster Brazil’s preparedness and response capabilities to health emergencies, particularly those Read More …
The Brazilian Health Regulatory Agency (ANVISA) recently approved a Regulatory Impact Analysis (RIA) report on medical cannabis. This development marks an important step towards the potential reshaping of cannabis regulations in Brazil, promising wide-ranging implications for public health, medical research, Read More …
Brazil’s Health Regulatory Agency (Anvisa) has commenced sample collections for the 2024 cycle of the Program for the Pesticide Residue Analysis in Food (Programa de Análise de Resíduos de Agrotóxicos em Alimentos – PARA). This initiative is crucial for monitoring Read More …
The latest release of Brazilian Health Regulatory Agency’s (ANVISA) “Labeling of Allergenic Foods” guidance in its sixth edition demonstrates the agency’s commitment to ensuring consumer safety and public health through enhanced allergen labeling standards. This revision places a strong emphasis Read More …
The Brazilian Health Regulatory Agency (Anvisa) upheld the prohibition on electronic smoking devices (ESDs), commonly known as electronic cigarettes. The decision is the outcome of a regulatory process that reviewed the regulation of these products in the country in light Read More …
ANVISA has launched Call No. 1, aimed at supporting the development of phytotherapeutic drugs, new synthetic drugs and biological products of interest to healthcare services by medical startups. Recognizing the critical need for new medications and the importance of nurturing Read More …
Brazil has been selected by the Codex Alimentarius, a joint program of the Food and Agriculture Organization (FAO) and the World Health Organization (WHO), for a study to evaluate the impact of international practices to prevent naturally occurring mycotoxins in Read More …
As Brazil faces a new epidemic of dengue fever, the impact on the country’s economy and workforce is becoming increasingly evident. The Ministry of Health’s Arbovirus Monitoring Panel reports a dengue incidence rate of 757.5 cases per 100,000 inhabitants, indicating Read More …
In the ever-evolving landscape of public health and safety, the Brazilian Health Regulatory Agency (Anvisa) plays a critical role in safeguarding the well-being of its citizens. The agency’s recent initiative to enhance transparency in its drug evaluation process is a Read More …